Parity as a Risk Factor for Differentiated Thyroid Carcinoma: A Population-based Study.
Dan R +4 more
europepmc +1 more source
Thyroid carcinoma follow-up: tertiary to primary care transition in Portugal. [PDF]
Barbosa R +3 more
europepmc +1 more source
Epidemiology, risk factor and prognostic factor of young differentiated thyroid carcinoma with distant metastasis: a retrospective cohort study. [PDF]
Yin L, Yin AH.
europepmc +1 more source
Navigating direct-to-consumer genetic testing: experiences, decisions and perspectives of Dutch users. [PDF]
Bruins D +6 more
europepmc +1 more source
Efficient and sustainable nanocatalyst based on dithiocarbamate ionic liquid functionalized magnetic graphene oxide for green synthesis of 1,4-dihydropyridins. [PDF]
Ghorbannia R, Baharfar R, Maleki B.
europepmc +1 more source
Characterization of the patient profile and efficacy of empirical radioiodine therapy in differentiated thyroid cancer with biochemical evidence without identified iodine-avid structural metastatic disease. [PDF]
Gomes FF +3 more
europepmc +1 more source
Thyroglobulin Autoantibodies Do Not Influence the Outcome of Patients With Differentiated Thyroid Carcinoma. [PDF]
Bornemann C, Bouter C.
europepmc +1 more source
Personalized prognosis: construction and validation of a survival prediction model for older postoperative differentiated thyroid cancer patients. [PDF]
Mu Y, Zhang S, Huang M, Feng G.
europepmc +1 more source

